Phase II Study of ET-743 [trabectedin] Therapy in Metastatic Osteosarcoma
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Trabectedin (Primary)
- Indications Osteosarcoma
- Focus Adverse reactions; Therapeutic Use
- 17 Dec 2009 Inclusion and exclusion criteria amended from NCT.
- 17 Dec 2009 Actual end date (Sep 2003) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.